Todos las publicaciones etiquetados con
COVID-19
Non-invasive oxygen therapy in patients with COVID-19: wu ji bi fan: too much of something is not good. Med Int Méx 2022; 38 38 (6): 1244-1253. https://doi.org/10.24245/mim.v38i6.7210 Jesús Salvador Sánchez-Díaz, Karla Gabriela Peniche-Moguel,…
Toxic hepatitis as manifestation of intoxication due to chlorine dioxide as prophylactic use against infection due to virus SARS-CoV-2. Med Int Méx 2022; 38 (5): 1132-1135. https://doi.org/10.24245/mim.v38i5.7045 Heriberto Martínez-Camacho,1 Lorena Morfín,2 Arabela Brito,2 Brandon Cruz2…
Extrapulmonary manifestations of COVID-19. Med Int Méx 2022; 38 (5): 1025-1040. https://doi.org/10.24245/mim.v38i5.4745 Luis Guillermo Moreno-Madrigal, Arturo Eduardo Hernández-Lima Medicina Interna, Hospital General Regional núm. 1 Dr. Carlos MacGregor Sánchez Navarro, Instituto Mexicano…
Clinic-ventilatory differences between patients with orotracheal intubation due to COVID-19 with criteria for tracheotomy compared with those without criteria. Med Int Méx 2022; 38 (4): 791-803. https://doi.org/10.24245/mim.v38i4.6940 Martha Jeanneth Jiménez-Rodríguez,1 Juan Antonio Lugo-Machado,2 Adrián…
Simultaneous systemic thrombosis as a manifestation of COVID-19. Med Int Méx 2022; 38 (4): 960-963. https://doi.org/10.24245/mim.v38i4.7399 Jesús Samuel Borges-López,1 Adán Rafael Mares-Orozco,1 José Luis Barón-Caballero,2 Eduardo Ayala-Hernández,3 Luis Manuel Borges-López4 1 Servicio de Cardiología. 2 Servicio de Ecocardiografía….
Cytokine release syndrome in infection due to COVID-19 and administration of tocilizumab as therapeutic option. Med Int Méx 2022; 38 (4): 877-886. https://doi.org/10.24245/mim.v38i4.4869 Mónica Prado-Rodríguez, Yovani Robles-Abarca, Brenda Lizette González-Rocha, Fernando Soler-Delgado,…
Separation of blood components in patients critically ill with COVID-19. Med Int Méx 2022; 38 (4): 825-830. https://doi.org/10.24245/mim.v38i4.5846 Oscar A Peñuela-Briceño,1 Lina A Gómez2 1 MSL Field Manager in Bayer Pharmaceuticals, Chía, Colombia. 2 Centro…
Effect of communication with mobile devices in hospitalized patients due to COVID-19. Med Int Méx 2022; 38 (4): 804-810. https://doi.org/10.24245/mim.v38i4.6942 Miguel Ángel Fernández-Ortega,1 Paola Nájera-Chávez,2 Efrén Raúl Ponce-Rosas,5 Rocío Dávila-Mendoza,6 Daniel Alejandro Muñiz-Salinas,7 Omar Rodríguez-Mendoza,8 Verónica Sánchez-Pozos,3 Carlos Lenin…
D dimer concentration variation as predictor of mortality in patients with COVID-19. Med Int Méx 2022; 38 (4): 760-766. https://doi.org/10.24245/mim.v38i4.5350 Juan Luis Ontiveros-Austria,1 Karina Teresita González-Rodríguez,2 Eduardo Armando Reyes-Rodríguez,3 Elizabeth Vicencio-Lomelí,4 Juan Manuel Sánchez-Sánchez,5 Bruno Alexander Velázquez-Guevara,1 Jessica…
Cutaneous reactions associated with vaccination against SARS-CoV-2. Med Int Méx 2022; 38 (3): 727-732. https://doi.org/10.24245/mim.v38i3.7066 Génesis Alejandra Cabral-Rodríguez,1 Juan Oziel Romero-Tafoya,1 Christian García-Estrada2 1 Residente de Medicina Interna. 2 Internista-neurólogo. Departamento de Medicina Interna, Hospital General…